Latest Feature

Kimberly-Clark readies Halyard Health medical device spinout

Halyard Health, the publicly traded, $1.6 billion spinout of Kimberly-Clark's medical device business, is slated to go live in November, soon-to-be COO Chris Lowery tells MassDevice.com.

HART CEO David Green on the transformative potential for regenerative medicine

David Green tells MassDevice.com about the decision to split Harvard Bioscience and Harvard Apparatus Regenerative Technology, his choice to move over to the new entity and why regenerative technologies are poised to transform medicine.

Wound care by the numbers: Q&A with Alliqua CEO Dave Johnson

Medtech veteran Dave Johnson has been with Alliqua Biomedical for less than 2 years, during which time he's overseen a major hiring spree, 3 business development deals and the company's 1st acquisition. In an interview with MassDevice.com, Johnson talks about his step-by-step perspective and where he hopes Alliqua will be in 5 years.

Podcast: Medtech legends and leaders on the state of medical device innovation

MassDevice.com brought together 4 of the most influential leaders in medtech to discuss the future of the industry on July 15, 2014 at DeviceTalks Boston.

CardioMEMS took 11 years to pay off, but for Boston Millennia it was worth it

Boston Millennia's managing general partner Dana Callow discusses the 11-year journey to bring CardioMEMs implantable heart monitor to market and what his venture capital firm sees for the future of medtech investment.

Subscribe to the MassDevice
Newsletter
Enter your email:

Need Medtech news in a minute? We Deliver!


MassDevice +3,+5 and +7 newsletters get you caught up on all the mission critical news you need in med tech. Sign up today for our free newsletter.

Intersect ENT study aims to bring sinus implants to more patients

September 19, 2014 by Arezu Sarvestani

Intersect ENT enrolls the 1st patient in its PROGRESS study, aiming to expand the patient population for its steroid-eluting sinus implants.

Intersect ENT study aims to bring sinus implants to more patients

California device maker Intersect ENT (NSDQ:XENT) announced this week that it enrolled the 1st patient in its PROGRESS clinical trial, evaluating the company's Propel Mini sinus implant for treatment of frontal sinusitis.

Press Release: NxStage announces FDA clearance of Single Needle Technology

September 18, 2014 by MassDevice

Innovative needle design to enhance patient safety.

Press Release: NxStage announces FDA clearance of Single Needle Technology

LAWRENCE, Mass. -- 

NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced its single needle technology, OneSite, has received FDA clearance.

NxStage Medical's single-needle home dialysis system comes to the U.S.

September 18, 2014 by Arezu Sarvestani

NxStage Medical wins FDA clearance to market its OneSite single needle dialysis technology for use with its portable systems.

NxStage Medical's single-needle home dialysis system comes to the U.S.

Massachusetts-based dialysis devices maker NxStage Medical (NSDQ:NXTM) won FDA clearance for its OneSite technology, cutting down on the number of needles dialysis patients must endure during therapy.

Medtronic taps Brigham & Women's prez Nabel for board | Personnel Moves

September 18, 2014 by Brad Perriello

Medtronic taps Dr. Elizabeth Nabel, president of Brigham & Women's Faulkner Hospital in Boston, for a seat on its board of directors.

Medtronic taps Brigham & Women's prez Nabel for board | Personnel Moves

MassDevice.com +3 | The top 3 medtech stories for September 18, 2014

September 18, 2014 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

Zimmer signs allograft distro agreement with MiMedx

September 18, 2014 by Arezu Sarvestani

MiMedx licenses its dHACM allografts to orthopedics giant Zimmer non-exclusively on a private label basis.

Zimmer signs allograft distro agreement with MiMedx

Medtronic and Covidien prepare 1st Integration Summit

September 18, 2014 by Arezu Sarvestani

Merging medtech titans Medtronic and Covidien are preparing to host the 1st of 4 Integration Summits, scheduled later this month.

Medtronic and Covidien prepare 1st Integration Summit

Apple's HealthKit delayed over bugs

September 18, 2014 by Arezu Sarvestani

Apple delays today's launch of its "revolutionary" HealthKit mobile health and fitness program after finding that prevent it from working with other apps.

Apple's HealthKit delayed over bugs

Apple's (NSDQ:AAPL) latest iOS 8 operating system hit the market this week, but it's missing one important piece: the HealthKit software.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp